|
Number |
Date |
Subject |
|
2006 |
|
3 |
23 March |
Capital increase of DKK 5,791,250 (579,125 shares of DKK 10) in Bavarian Nordic A/S finalised |
|
2 |
22 March |
Bavarian Nordic A/S – Annual results 2005 |
|
1 |
16 February |
Bavarian Nordic A/S further enforces its intellectual property rights against Acambis |
|
2005 |
|
37 |
28 December |
European patent issued to Bavarian Nordic A/S on MVA-BN® |
|
36 |
22 December |
Bavarian Nordic Status |
|
35 |
6 December |
Bavarian Nordic A/S included in Morgan Stanley Capital International’s Small Cap Index and announces 2006 Finance Calendar |
|
34 |
27 October |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
33 |
26 October |
Bavarian Nordic A/S – Third quarterly report as of 30 September 2005 |
|
32 |
21 September |
U.S. International Trade Commission initiates investigation against Acambis plc MVA smallpox vaccine products on Bavarian Nordic A/S complaint |
|
31 |
22 August |
Interim results as of 30 June 2005 and update on company developments |
|
30 |
19 August |
Bavarian Nordic A/S enforces its intellectual property rights against Acambis plc and Acambis Inc. |
|
29 |
16 August |
US Government issues RFP-III for the purchase of 20 million doses of MVA-based smallpox vaccine |
|
28 |
20 July |
Bavarian Nordic initiate a phase II clinical trial with IMVAMUNE™ in HIV-infected patients |
|
27 |
5 July |
Bavarian Nordic A/S receives US patent on MVA |
|
26 |
22 June |
Bavarian Nordic’s Rights Issue fully subscribed |
|
25 |
20 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
24 |
15 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
23 |
14 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
22 |
13 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
21 |
10 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
20 |
9 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
19 |
8 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
18 |
7 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
17 |
6 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
16 |
3 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
15 |
2 June |
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such |
|
14 |
19 May |
Bavarian Nordic A/S publishes prospectus for rights issue |
|
13 |
15 May |
US Health authorities issue draft RFP-III on the public tender for the purchase of up to 80 million doses of MVA-based smallpox vaccine |
|
12 |
10 May |
Bavarian Nordic A/S – Quarterly report for the first quarter of 2005 |
|
11 |
3 May |
Bavarian Nordic A/S issues revised financial calendar for 2005 |
|
10 |
26 April |
Bavarian Nordic A/S – Report on the results of the annual meeting, held 26 April 2005 |
|
9 |
7 April |
Update on the manufacturing facility in Kvistgård |
|
8 |
5 April |
Notice convening ordinary general meeting in Bavarian Nordic A/S |
|
7 |
1 April |
Bavarian Nordic A/S – Quarterly statement of share ownership |
|
6 |
3 March |
Bavarian Nordic A/S – Annual Results 2004 |
|
5 |
1 March |
Bavarian Nordic A/S issues revised financial calendar for 2005 |
|
4 |
24 February |
Bavarian Nordic A/S provides update on business and development activities |
|
3 |
17 February |
Bavarian Nordic A/S’ German manufacturing facility approved by legal authority |
|
2 |
14 February |
Bavarian Nordic A/S to raise new capital for vaccine production and product development and publishes its expectations for 2005 |
|
1 |
3 January |
Bavarian Nordic A/S – Quarterly statement of share ownership |
